Pharmaceutical manufacturer for Thiamine hydrochloride

Suven Pharmaceuticals Limited, an organization established in November 2018, has transformed into a Wholly Owned Subsidiary of Suven Life Sciences Limited, effective from February 2019. Suven Life Sciences Limited, following the Board meeting on February 5, 2019, declared the demerger of Suven Life Sciences Limited into two parts: Suven Life Sciences Limited, the demerged entity, will persist in pioneering research dedicated to Central Nervous System (CNS) disorders to address significant unmet medical needs worldwide. Suven Pharmaceuticals Limited, the resulting entity, will carry on the CRAMS business operations.

Biophore, founded in 2007, has established itself as a dependable partner in the development and production of unique and intricate pharmaceutical products. With 4 USFDA and EU-certified API manufacturing facilities, a specialized intermediate facility, and a research and development laboratory accommodating 400 scientists, Biophore has positioned itself as a worldwide leader among API companies. It consistently ranks among the top 10 US DMF submitters and has acquired over 150 patents globally in process and polymorph areas. Biophore's facilities have an impressive history of successful inspections by regulatory authorities such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.

Rochem International, Inc. has been a prominent distributor of pharmaceutical, food, nutritional, and animal health ingredients since its establishment in 1994. It procures top-notch ingredients produced in China. With its headquarters in Hauppauge, New York, Rochem operates 16 global offices to meet its clients' requirements. The company's activities adhere to cGMP standards and have undergone audits by the USFDA and various multinational entities. Furthermore, it provides training and conducts audits for its partners to ensure FDA compliance for their technologies and systems.

Cdymax (India) Pharma Private Limited was established in 1994. The organization's primary function involves the production, construction, or transformation of medications in pharmaceutical formulations for either human or veterinary application. CDYMAX guarantees and complies with HSE guidelines. Systems and protocols are implemented to oversee and regulate. All staff members undergo routine health assessments annually, and twice a year for oncology personnel. The wastewater treatment facility meets governmental standards.

TopChem Pharmaceuticals Limited was founded in 2006 as a recently established GMP provider of APIs and associated assistance to the Pharmaceuticals industry on a global scale. TopChem focuses on specialized, low-volume APIs and excipients that are frequently challenging for Drug Product companies to obtain. Our product range demonstrates the variety of products we have created. Please reach out to us if you are unable to locate a specific API or Excipient. The majority of our products have been developed to meet individual customer needs. If necessary, we can provide global or territorial exclusivity.

Our mission is to utilize scientific knowledge and imaginative thinking to contribute to a more positive global environment. Combining the elegance of artistic expression with the exactness of scientific methodology, we are a diverse international group of intellectuals who collaborate with clients to provide fragrances, flavors, experiences, components, and solutions for the products that the world desires. As a prominent figure in the fields of food, beverages, health, biosciences, and sensory experiences on a worldwide scale, we engage in extensive activities and continuously strive to enhance them. For over a century and three decades, our primary focus has been on discovering the most pioneering approaches to assist in the introduction of products that are beneficial for consumers.

Brother Enterprises Holding Co., Ltd. was established in 1991, with its main office situated in Haining City, Zhejiang Province